Scarica l'app Stockscreener
18.08
4.09%
0.71
Dopo l'orario di chiusura:
18.40
0.32
+1.77%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SCLX Giù?
Forum
Previsione
Precedente Chiudi:
$17.37
Aprire:
$17.62
Volume 24 ore:
540.39K
Relative Volume:
3.06
Capitalizzazione di mercato:
$125.69M
Reddito:
$46.74M
Utile/perdita netta:
$-114.33M
Rapporto P/E:
-14.02
EPS:
-1.29
Flusso di cassa netto:
$-21.04M
1 W Prestazione:
+15.01%
1M Prestazione:
+168.65%
6M Prestazione:
+45.92%
1 anno Prestazione:
-58.34%
Intervallo 1D:
$17.40
$20.40
Intervallo di 1 settimana:
$15.37
$22.01
Portata 52W:
$3.60
$46.20
Scilex Holding Company Stock (SCLX) Company Profile
Nome
Scilex Holding Company
Settore
Industria
Telefono
(650) 516-4310
Indirizzo
960 SAN ANTONIO ROAD, PALO ALTO
Confronta SCLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SCLX
Scilex Holding Company
|
18.08 | 98.10M | 46.74M | -114.33M | -21.04M | -1.29 |
|
LLY
Lilly Eli Co
|
701.23 | 613.56B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
176.64 | 420.78B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
206.69 | 361.58B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
124.21 | 236.35B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
84.21 | 206.72B | 63.43B | 16.42B | 14.72B | 6.49 |
Scilex Holding Company Stock (SCLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-27 | Iniziato | D. Boral Capital | Buy |
| 2024-10-16 | Iniziato | Alliance Global Partners | Buy |
| 2024-06-13 | Iniziato | Rodman & Renshaw | Buy |
| 2023-10-16 | Iniziato | B. Riley Securities | Buy |
| 2023-10-13 | Iniziato | B. Riley Securities | Buy |
| 2023-10-09 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Scilex Holding Company Borsa (SCLX) Ultime notizie
Scilex gains on spinoff plans for pharma subsidiary - MSN
Scilex Holding Soars 20.81% on SEC Approval, Funding, Partnership - AInvest
Scilex Holding Company Equity Warrant Stock Lags Behind Sector BenchmarksJuly 2025 Chart Watch & Free Low Drawdown Momentum Trade Ideas - beatles.ru
Scilex Holding Company shares fall 1.14% after-hours as SEC declares effectiveness of S-4 filing for Denali-Semnur merger. - AInvest
Scilex Holding Company ($SCLX) Stock: Surges Over 17% as SEC Clears Path for Denali-Semnur Merger Vote in September - CoinCentral
Scilex Holding shares surge 13.84% intraday after SEC approves Denali Capital Acquisition Corp. and Semnur Pharmaceuticals merger. - AInvest
Scilex Holding Company shares rise 6.34% premarket after announcing $100 million in funding from Tumim Stone Capital. - AInvest
Scilex Holding Company Announces S-4 Effectiveness, Denali-Semnur Merger Proposal, and Oramed Pharmaceuticals Enters Option Agreement with Scilex - AInvest
Scilex announces S-4 effectiveness for Denali-Semnur merger proposal - MarketScreener
Scilex Holding Company (Nasdaq: SCLX) Announces - GlobeNewswire
Denali's registration statement declared effective, extraordinary meeting scheduled. - AInvest
Scilex Announces Effectiveness of Registration Statement for Proposed Business Combination with Semnur Pharmaceuticals - AInvest
Biotech firm Scilex Advances SPAC Deal as SEC Approves Merger Registration for Pain Treatment Subsidiary - Stock Titan
Analysts Apply Wyckoff Model to Scilex Holding Company StockWeekly Trade Review & High Return Trade Opportunity Guides - beatles.ru
Scilex Holding Co expected to post a loss of 91 cents a shareEarnings Preview - TradingView
Scilex (SCLX) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Scilex Holding SCLX 2025Q2 Earnings Preview Upside Potential on Robust Revenue Growth - AInvest
Scilex Holding WRT SCLXW Q2 2025 Earnings Preview Upside Potential on Improved Cost Management - AInvest
Using R and stats models for Scilex Holding Company forecastingChart Based Entry Tool for ROI Traders - Newser
Quantitative breakdown of Scilex Holding Company recent moveYield Curve Outlook and Long-Term Implication Summary - Newser
How Scilex Holding Company Equity Warrant stock performs during market volatilityForecasting Stock Moves with AI Insights - Newser
Full technical analysis of Scilex Holding Company Equity Warrant stockFree Expert Verified Stock Trade Ideas - Newser
Is Scilex Holding Company Equity Warrant stock a growth or value playFree Capital Protection Trading Strategies - Newser
Scilex Holding Company Announces that Its Note Holders Intend to Participate in the Funding and Licensing of Gloperba® Ex-U.S. Commercialization Rights from Romeg Therapeutics, LLC - The Globe and Mail
Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication - The Globe and Mail
Scilex Holding Company Equity Warrant stock momentum explainedHigh Confidence Strategy with Trend Alignment - Newser
Should you wait for a breakout in Scilex Holding Company Equity WarrantShort Term Momentum Based Trading Strategy - Newser
Is Scilex Holding Company meeting your algorithmic filter criteriaPre-Market Stock Movement Summary and Review - Newser
Using Python tools to backtest Scilex Holding Company strategiesReal-Time Investment Picks with Accuracy - Newser
Competitive Positioning of Scilex Holding Company: Is It Leading or LaggingAlpha Stock Picks with Chart Confirmation - Newser
Scilex Holding Company stock trendline breakdownFree Fast Entry High Potential Stock Alerts - Newser
Can swing trading help recover from Scilex Holding Company Equity Warrant lossesFree Real Market Momentum Signal Generator - Newser
Live market analysis of Scilex Holding Company Equity WarrantFree Investment Plan With Growth Optimization - Newser
Scilex Holding Company Equity Warrant Company’s Quarterly Earnings Growth: What the Numbers SayFree Short Term Buy List With Stop Protection - Newser
Scilex files to sell 1.39M shares of common stock for holders - MSN
Backtesting results for Scilex Holding Company Equity Warrant trading strategiesExpert-Backed High Yield Stock Watchlist - Newser
What high frequency data says about Scilex Holding CompanySwing Entry Risk Mitigation with Chart Analysis - Newser
[S-1] Scilex Holding Company Warrant Files IPO Registration Statement | SCLXW SEC FilingForm S-1 - Stock Titan
Scilex Holding Company’s Beta Climbs After Market VolatilityCommunity Strategy With High Win Rate Backtested - metal.it
What are Scilex Holding Company company’s key revenue driversUnlock real-time trading signals for gains - Jammu Links News
Risk adjusted return profile for Scilex Holding Company Equity Warrant analyzedCapital Safe Picks with Consistent Gains - Newser
Is it the right time to buy Scilex Holding Company stockAchieve consistent returns with proven methods - Jammu Links News
What is the risk reward ratio of investing in Scilex Holding Company stockUnlock powerful market analysis and alerts - Jammu Links News
What catalysts could drive Scilex Holding Company Equity Warrant stock higher in 2025Outstanding stock performance - Jammu Links News
How strong is Scilex Holding Company company’s balance sheetBuild wealth steadily with proven stock picks - Jammu Links News
How does Scilex Holding Company Equity Warrant generate profit in a changing economyAchieve consistent profits with expert strategies - Jammu Links News
Is it the right time to buy Scilex Holding Company Equity Warrant stockRapid growth opportunities - Jammu Links News
Why is Scilex Holding Company Equity Warrant stock attracting strong analyst attentionExceptional ROI - Jammu Links News
Is Scilex Holding Company Equity Warrant a growth stock or a value stockTriple-digit wealth increases - Jammu Links News
Is Scilex Holding Company a good long term investmentHigh-velocity capital appreciation - Jammu Links News
Scilex Holding Company Stock Analysis and ForecastUnlock steady growth with low-risk stocks - Jammu Links News
Scilex Holding Company Azioni (SCLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.49%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):